Hippocampal neurotoxicity of Δ9-tetrahydrocannabinol

被引:170
|
作者
Chan, GCK [1 ]
Hinds, TR [1 ]
Impey, S [1 ]
Storm, DR [1 ]
机构
[1] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA
来源
JOURNAL OF NEUROSCIENCE | 1998年 / 18卷 / 14期
关键词
THC; cannabinoid receptors; CB1; cell death; hippocampal neurons; arachidonic acid; reactive oxygen species; SR141716A;
D O I
10.1523/JNEUROSCI.18-14-05322.1998
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Marijuana consumption elicits diverse physiological and psychological effects in humans, including memory loss. Here we report that Delta(9)-tetrahydrocannabinol (THC), the major psychoactive component of marijuana, is toxic for hippocampal neurons. Treatment of cultured neurons or hippocampal slices with THC caused shrinkage of neuronal cell bodies and nuclei as well as genomic DNA strand breaks, hallmarks of neuronal apoptosis. Neuron death induced by THC was inhibited by nonsteroidal anti-inflammatory drugs, including indomethacin and aspirin, as well as vitamin E and other antioxidants. Furthermore, treatment of neurons with THC stimulated a significant increase in the release of arachidonic acid. We hypothesize that THC neurotoxicity is attributable to activation of the prostanoid synthesis pathway and generation of free radicals by cyclooxygenase. These data suggest that some of the memory deficits caused by cannabinoids may be caused by THC neurotoxicity.
引用
收藏
页码:5322 / 5332
页数:11
相关论文
共 50 条
  • [1] Δ9-Tetrahydrocannabinol Prevents Methamphetamine-Induced Neurotoxicity
    Castelli, M. Paola
    Madeddu, Camilla
    Casti, Alberto
    Casu, Angelo
    Casti, Paola
    Scherma, Maria
    Fattore, Liana
    Fadda, Paola
    Ennas, M. Grazia
    PLOS ONE, 2014, 9 (05):
  • [2] Δ9-Tetrahydrocannabinol protects hippocampal neurons from excitotoxicity
    Gilbert, Glenna L.
    Kim, Hee Jung
    Waataja, Jon J.
    Thayer, Stanley A.
    BRAIN RESEARCH, 2007, 1128 (01) : 61 - 69
  • [3] Separate and combined effects of gabapentin and 9-tetrahydrocannabinol in humans discriminating 9-tetrahydrocannabinol
    Lile, Joshua A.
    Wesley, Michael J.
    Kelly, Thomas H.
    Hays, Lon R.
    BEHAVIOURAL PHARMACOLOGY, 2016, 27 (2-3): : 215 - 224
  • [4] Acute effects of Δ9-tetrahydrocannabinol and cannabidiol on hippocampal glutamate and GABA levels
    Solowij, N.
    Van Hell, H.
    Broyd, S.
    Suo, C.
    Yucel, M.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 : S323 - S323
  • [5] Magnesium deficiency reveals the neurotoxicity of Δ-9-tetrahydrocannabinol (THC) low doses in rats
    Bac, P
    Pages, N
    Herrenknecht, C
    Maurois, P
    Durlach, J
    MAGNESIUM RESEARCH, 2003, 16 (01) : 21 - 28
  • [6] Chronic Δ9-tetrahydrocannabinol treatment inhibits hippocampal acetylcholine release in rats
    Carta, G
    Nava, F
    Casu, MA
    Mascia, S
    Gessa, GL
    EUROPEAN JOURNAL OF NEUROSCIENCE, 1998, 10 : 309 - 309
  • [7] Substitution profile of Δ9-tetrahydrocannabinol, triazolam, hydromorphone, and methylphenidate in humans discriminating Δ9-tetrahydrocannabinol
    Joshua A. Lile
    Thomas H. Kelly
    David J. Pinsky
    Lon R. Hays
    Psychopharmacology, 2009, 203 : 241 - 250
  • [8] Sublingual administration of Δ9-tetrahydrocannabinol/β-cyclodextrin complex increases the bioavailability of Δ9-tetrahydrocannabinol in rabbits
    Mannila, J
    Järvinen, T
    Järvinen, K
    Tervonen, J
    Jarho, P
    LIFE SCIENCES, 2006, 78 (17) : 1911 - 1914
  • [9] Substitution profile of Δ9-tetrahydrocannabinol, triazolam, hydromorphone, and methylphenidate in humans discriminating Δ9-tetrahydrocannabinol
    Lile, Joshua A.
    Kelly, Thomas H.
    Pinsky, David J.
    Hays, Lon R.
    PSYCHOPHARMACOLOGY, 2009, 203 (02) : 241 - 250
  • [10] Determination of Δ9-tetrahydrocannabinol in food
    Georgi, K
    Mavric, E
    Speer, K
    DEUTSCHE LEBENSMITTEL-RUNDSCHAU, 2002, 98 (10) : 363 - 366